Bayer Trims Consumer Portfolio Selling Solarcaine, Other US, Canada Skin Care Brands To WellSpring
Executive Summary
WellSpring, owned by private equity firm Avista Capital Partners, purchasing Solarcaine, diaper rash and skin protectant A+D and Canadian brands Cortate and Complex 15. Bayer’s long-term commitment to consumer health one of key issues facing its next CEO, Bill Anderson.
You may also be interested in...
Perrigo’s Next CEO Has Long OTC Brands History
Patrick Lockwood-Taylor starts as president/CEO on 30 June, succeeding Murray Kessler as Perrigo awaits FDA decision on subsidiary HRA’s proposal for first US OTC sales of daily oral contraceptive. He’s moving from president of Bayer AG’s US business and regional president, consumer health North America.
Top Five Takeaways From Bayer Consumer Health's 2022 Results
Beating global market growth, continuing macroeconomic headwinds and spin-off perspectives were among the key talking points as Bayer Consumer Health reported its 2022 sales and earnings.
Bayer’s Incoming CEO Faces Consumer Health Decision
Activist investors are pushing for a break-up of Bayer's conglomerate structure and the sale of its Consumer Health division. It will be up to incoming CEO Bill Anderson to make the call.